Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 83.2B | 86.6B | 85.6B | 94.6B |
Cost of revenue | 78.6B | 82.3B | 83.7B | 89.8B |
Gross profit | 4.6B | 4.3B | 1.9B | 4.8B |
Operating expense | ||||
Research & development | 542.2M | 577.6M | 525.8M | 594.4M |
Selling general and admin | 2.7B | 2.8B | 2.6B | 2.9B |
Other operating expenses | — | — | — | — |
Operating income | 1.4B | 960.6M | -1.2B | 1.3B |
Non operating interest income | ||||
Income | 258.3M | 271.6M | 240.4M | 488.2M |
Expense | 1.2B | 1.2B | 968.1M | 951.2M |
Other income expense | — | — | — | — |
Pretax income | 1.1B | 936.2M | 142.9M | 2.0B |
Tax provision | 304.4M | 41.7M | -66.7M | 379.6M |
Net income | 813.8M | 894.5M | 209.7M | 1.6B |
Basic EPS | 0.0 | — | 0.0 | 0.1 |
Diluted EPS | 0.0 | — | 0.0 | 0.1 |
Basic average shares | 15.2B | — | 15.3B | 14.7B |
Diluted average shares | 15.3B | — | 15.3B | 14.7B |
EBITDA | 10.8B | 10.5B | 9.2B | 10.9B |
Net income from continuing op. | 1.1B | 936.2M | 142.9M | 2.0B |
Minority interests | -570.6M | -799.7M | -291.0M | -316.0M |
Preferred stock dividends | 0 | 0 | 0 | 0 |